R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study is a multicentric randomized trial evaluating the efficacy and safety of R-CHOP
given every 14 days compared to R-CHOP given every 21 days in association or not with
darbepoetin alfa in order to maintain hemoglobin above 13 g/dl, compared to classical
symptomatic treatment of anemia in patients aged from 60 to 80 years with diffuse large
B-cell lymphoma.